Patients with non-ischaemic systolic heart failure often have reduced myocardial blood flow without significant coronary atherosclerosis. Likewise, patients with atrial fibrillation (AF) have reduced myocardial perfusion during AF compared with sinus rhythm. The aim of this study was to explore whether there is an additive negative effect of AF during scan on the myocardial perfusion in patients with non-ischaemic systolic heart failure. 
Introduction
Reduced myocardial flow reserve (MFR = stress flow/rest flow), has been found in patients with non-ischaemic systolic heart failure despite of no significant coronary atherosclerosis.
1,2 Different explanations have been suggested including endothelial dysfunction and impaired angiogenesis leading to impaired perfusion, resulting in myocardial ischaemia. 3 Nevertheless, the mechanism behind the impaired perfusion remains unclear. Moreover, in patients with atrial fibrillation (AF), haemodynamic parameters of the left ventricle are impaired.
Reduced myocardial blood flow (MBF) under rest and adenosine stress conditions has been found in patients with AF compared with age-and risk-matched controls and young controls 4 as well as in patients with non-ischaemic systolic heart failure and AF compared with those having sinus rhythm. 5 Studies posit that the lower myocardial perfusion in patients with AF is associated with the irregularity in the ventricular rhythm and not with a higher heart rate. 6, 7 It is unknown, whether there is an additive reduced MFR in patients with both non-ischaemic systolic heart failure and AF. Rb) positron emission tomography (PET)/computed tomography (CT) perfusion for quantification of MBF is a robust method 8, 9 and makes the detection of microvascular disease possible before occurrence of structural epicardial coronary artery disease. To our knowledge, myocardial perfusion in patients with non-ischaemic systolic heart failure with and without AF has not previously been measured with 82 Rb-PET/CT. To enable a targeted treatment, it may be important to investigate the myocardial perfusion in patients with non-ischaemic systolic heart failure and AF further. Therefore, we used MFR by 82 Rb-PET/CT to investigate whether changes in myocardial perfusion are associated with AF in patients of both sexes with non-ischaemic systolic heart failure, and whether there is an additive effect.
Methods

Study population
In this study, we included patients with non-ischaemic systolic heart failure from the DANISH Study (A DANish randomized, controlled, multicenter study to assess the efficacy of Implantable cardioverterdefibrillator in patients with non-ischaemic Systolic Heart failure on mortality). 10 Patients were included in our sub-study late in the follow-up period of the DANISH study. Patients were recruited according to the original DANISH study inclusion criteria: age >18 years, documented non-ischaemic systolic heart failure [left ventricular ejection fraction (LVEF) < _35%], and increased levels (>200 pg/mL) of N-terminal probrain natriuretic peptide (NT-proBNP) despite optimal medical treatment. Patients were excluded according to following criteria: severe chronic obstructive lung disease (COPD)/asthma, blood pressure >200/ 110 mmHg or systolic blood pressure <90 mmHg, diabetes mellitus, allergy or intolerance to adenosine or theophylline, pregnancy, and inability to adhere to the protocol. From May 2015 to September 2016, we scanned 114 patients with non-ischaemic systolic heart failure without diabetes using 82 Rb-PET. Of the 114 patients, 23 patients had AF during the scan. The inclusion flowchart is shown in Figure 1 . Further, we included 27 young healthy controls between September 2016 and March 2017. Informed oral and written consents were obtained from all patients and controls, and the Scientific Ethics Committee of the Capital Region of Denmark and the Danish Data Protection Agency approved the protocols (Protocol numbers H-15000346 and H-15009293). We performed the trial in accordance with the principles of the Declaration of Helsinki.
PET/CT imaging
In one session, all participants underwent PET myocardial perfusion imaging at rest and during adenosine-stress. We instructed the participants not to consume substances and medications containing caffeine and theophylline for 12 h before the scan. All medications for heart failure were continued. Patients Rb generator manufactured for Bracco Diagnostics Inc., Princeton, NJ, USA. We utilized a Siemens Biograph mCT/PET 128-slice scanner (Siemens Healthcare, Knoxville, TN, USA), and both rest and stress images were acquired ECG-gated in list mode for 7 min from the 82 Rb infusion start point. As stressor, we used adenosine infusion (0.14 mg/kg/min) for 6 min, and we started the stress 82 Rb infusion 2.5 min after initiating the adenosine administration. Moreover, we performed a low-dose CT for attenuation correction before the rest study, and repeated it after the stress study in case of patient motion. As per clinical routine, we acquired coronary artery calcium score (CACS) images from a non-contrast breath-hold CT in all patients. We calculated the CACS according to the Agatston score system.
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Quantitative and semi-quantitative analyses MBF quantification of dynamic rest and stress images was conducted as described in details by Armstrong et al. 12 The MBF quantification was conducted with quantitative gated nuclear imaging: QGS/QPS v. 2015 Rb tracer kinetics model. The definition of MFR was MBF at adenosine-induced maximal hyperaemia divided by resting MBF. Rate pressure product (RPP) was calculated, defined as the systolic blood pressure, times the heart rate. To correct MBF for baseline work, we divided resting MBF with RPP and multiplied by 10 000. 14 Additionally, we divided MFR into low (< _2.0), borderline (>2.0-2.5), and normal (>2.5) according to previous suggestions. 15 For resting and stress, MBF normal values were defined as 0.82 mL/g/min ±30% and 3.3 mL/g/min ±31%, respectively. 16 Further we measured the coronary vascular resistance (CVR) calculated as mean arterial pressure divided by MBF at rest and at stress. The irreversible and reversible regional perfusion defects were automatically computed as summed rest score (SRS), summed stress score (SSS), and summed difference score (SDS = SSSÀSRS) with the QPET software from Cedars-Sinai, in accordance with the AHA 17 myocardial segment model. 17 The definition of SSS was: 0-3:
normal (<5% myocardium with perfusion abnormalities), 4-7: mildly abnormal (5-10% myocardium with perfusion abnormalities), and > _8 moderately or severely abnormal (>10% myocardium with perfusion abnormalities). 18 LVEF was calculated by the software as well.
Statistical analyses
For the statistical analyses, we used SAS version 9.4 (SAS Institute, Cary, NC, USA). Categorical variables were expressed in percentages. Continuous variables were expressed as medians and IQRs. We analysed differences between groups with the v 2 test for categorical variables and unpaired t-test, after log-transformation of variables necessary to obtain a normal distribution, or Wilcoxon two-sample test for continuous variables. For multivariable regression analyses of explanatory variables (sex, age, body mass index, hypertension, N-terminal pro-brain natriuretic peptide, LVEF at baseline, left ventricular bundle branch block, left ventricular mass, change in heart rate from rest to stress, and CACS), we used the general linear model procedure. P-values <0.05 were considered statistically significant.
Results
The 114 patients in this study were largely comparable to the rest of the study population of the main study, comparing only with those without diabetes and COPD as in our current study population (Supplementary data online, Table S1 ). The main differences were a significantly lower NT-proBNP in our study population (794 vs. 1191; P = 0.02) and fewer with CRT (49% vs. 60%, P = 0.04). Beyond these variables, the patients in this substudy were similar to the remaining patients in the main study without diabetes and COPD. Patient demographics are summarized in Table 1 . We found that patients with AF during scan were older than patients without (73 years; IQR 65-78 years vs. 67 years; IQR 60-74 years; P = 0.03) and a higher proportion with AF were men (87% vs. 62%; P = 0.02). Anticoagulation treatment was more common among patients in the AF group (87% vs. 24%; P < 0.0001). Fewer patients with AF had left bundle branch block (9% vs. 72%; P < 0.0001), and also fewer were treated with cardiac resynchronization therapy (4% vs. 68%; P < 0.0001). Except from these variables, the two groups were similar.
In the control group, the median age was 23 years (IQR 22-25). The distribution of sex was 74% men and 26% women, which did not differ significantly from the two patient groups: with AF (P = 0.26); and without AF (P = 0.23). BMI was lower in the healthy young controls compared with both patients groups 22 .0 kg/m 2 (IQR 20.8-23.5; P < 0.0001).
PET/CT data
In Table 2 , we show findings from the 82 Rb PET/CT scan in patients with heart failure. CACS was similar in the two groups as was the amount of 82 Rb and adenosine administered. Patients with AF during scan had higher diastolic blood pressure at both rest (68 vs. 61 mg; P = 0.01) and stress (70 vs. 60 mg; P < 0.001). At rest, they also had higher heart rate (73 vs. 64; P < 0.01) and higher RPP (8148 vs. 6784 mmHg/s; P = 0.02). Of the 91 patients without AF during scan, 55% had pace rhythm from CRT and 45% had sinus rhythm. All controls had CACS of zero, no history of arrhythmias and were scanned in sinus rhythm.
Global MBF and MFR
Overall MFR was reduced (<2.5) in 74% of patients with AF during scan and 50% without. Perfusion results are shown in Table 2 . MFR was significantly lower in patients with AF during scan than patients with sinus/pace rhythm [MFR: 1.87 91 . This was significantly lower than in patients without AF (P = 0.01) but did not differ significantly from patients with AF (P = 0.14). After correction for RPP rest MBF in controls did no longer differ from patients with or without AF (1.26 mL/ g/min; IQR 1.02- 1.48 ; P = 0.27 and P = 0.11). Figure 3 illustrates correlations between MFR and MBF at rest and at stress for the two patient groups and the controls. The strongest correlation was found in patients with AF between MFR and MBF at stress (R 2 = 0.76).
A multivariable regression analysis including sex, age, body mass index, hypertension, N-terminal pro-brain natriuretic peptide, LVEF at baseline, left ventricular bundle branch block, left ventricular mass, change in heart rate from rest to stress, and CACS (Table 3) showed that MFR remained significantly lower in the group with AF during scan (estimate À24.2%; 95% CI À39.6% to À4.8%; P = 0.02). Running the same multivariable analysis for patients diagnosed with permanent AF (n = 20), we found the same significant lower in MFR (estimate À27.1%; 95% CI À42.9% to À7.1%; P = 0.01), whereas for all patients ever diagnosed with AF (n = 35, including 12 patients with sinus/pace rhythm during scan) the lower MFR became non-significant (estimate À16.6%; 95% CI À30.9% to 0.01%; P = 0.06). When considering only patients with AF during scan compared with patients with sinus rhythm and excluding all patients with CRT, we had a sample of 22 patients with AF that was compared with 28 patients in sinus rhythm. In this comparison, we also found that MFR was significantly lower in the patients with AF (MFR: 1.99 
CVR
CVR at rest and stress conditions is shown in Table 2 for patients and in Figure 4 for both patients and controls. Under adenosine stress conditions, CVR was significantly higher in patients with AF during scan [56 mmHg/(mL/g/min); 95% CI 44-68] compared with patients without AF [37 mmHg/(mL/g/min); 95% CI 33-40; P < 0.001] and
controls [29 mmHg/(mL/g/min); 95% CI 25-34; P < 0.0001]. Additionally, CVR was significantly higher in patients without AF compared with controls (P < 0.01). At rest, CVR was significantly lower in patients without AF [85 mmHg/(mL/g/min); 95% CI 81-90] compared with controls [100 mmHg/(mL/g/min); 95% CI 90-111; P < 0.01] and tended to be lower than in patients with AF [98 mmHg/ (mL/g/min); 95% CI 84-111; P = 0.054]. We found no difference in CVR at rest between patients with AF and controls (P = 0.58).
Regional myocardial perfusion defects
In all patients, we assessed the summed rest-, stress-, and difference scores (SRS, SSS, and SDS). There were no significant differences in the three scores when comparing the two groups with and without AF during scan ( Table 2) .
Discussion
In this prospective cross-sectional study, we utilized 82 Rb PET/CT imaging to assess MFR in patients with non-ischaemic systolic heart failure with and without AF during scan. Moreover, we compared MFR and CVR in both patient groups with a group of healthy young controls. We found that MFR was significantly lower in patients with AF during scan. This finding was confirmed in a multivariable analysis. In addition, global stress MBF was also significantly lower in the group with AF. Uncorrected rest MBF did not differ between groups, while correcting for RPP resting MBF became significantly lower in the AF group. These findings largely concurs with previous findings in a study of male patients with non-ischaemic systolic heart failure by Range et al. 5 Further MFR and MBF at stress were significantly lower in both patient groups compared with healthy young controls. Patients with AF had the strongest correlation between MFR and stress MBF and no correlation between MFR and resting MBF, indicating that MFR may depend on reduced stress MBF rather than a compensatory increase in rest MBF in these patients.
In our study, we did not find any differences in regional perfusion in the group with additional AF in comparison with sinus/pace rhythm. This indicates that the pathophysiologic mechanism of the impaired myocardial perfusion in the AF group is a global phenomenon. Our findings are similar to the results of Range et al. 5 To our knowledge, our study and the study in men by Range et al. 5 are the only two studies of myocardial perfusion in patients with heart failure and AF and 18 men with heart failure and sinus rhythm and found results akin with ours regarding adenosine stress MBF. In their study, both corrected and uncorrected resting MBF were lower in the men with AF. This was partly in contrast to our results. MFR tended to be lower in the men with AF, without reaching the level of significance. The nonsignificance of difference in MFR in the study by Range et al. is most likely due to lack of power caused by few subjects in their study. Furthermore, the authors observed increased rest and stress CVR in the AF group compared with patients without AF and in both patient groups compared with controls. Our study confirmed these findings regarding CVR at stress.
Other studies in patients with AF also substantiate our findings. In another study by Range et al., 4 also performed with H 15 2 O-PET, the authors also found that MFR was significantly lower in patients with AF compared with young control persons and also lower compared with matched control persons although the latter was not significant. In yet another study, Kochiadakis et al. 6 illustrated with Doppler that MFR was significantly lower measured during AF than both during right ventricular pacing at identical heart rate and during sinus rhythm. This finding puts forward that the lower myocardial perfusion in patients with AF is associated with the irregularity in the ventricular rhythm and cannot solely be explained by a higher heart rate. Results from Clark et al. 7 equally showed that the irregularity of the RR interval produces adverse haemodynamic consequences such as lower cardiac output, increased pulmonary capillary wedge pressure, and increased right atrial pressure independent of heart rate.
Our results from the multivariable analysis showed that the difference in heart rate increase from rest to stress between the two groups did not explain the difference in MFR. The irregularity in the heart rhythm could most likely also explain our findings of lower MFR in heart failure patients with AF during scan. Our results showed a significant correlation between current AF and MFR, whereas the correlation between a previous AF diagnosis and MFR was not significant. This may indicate that MFR could be potentially partly reversible. In the previous mentioned study by Range et al., CVR was increased in the AF group both at rest and stress conditions and in our study at stress conditions. This may also diminish the myocardial perfusion and different mediators are proposed by the authors: raised levels of atrial natriuretic peptide, brain natriuretic peptide, and angiotensin-converting enzyme. 5 In a study on healthy volunteers by Böttcher et al.,
19 myocardial resting blood flow was reduced by beta-1 blockade and MFR was increased, but no change in maximal hyperaemic response to pharmacological stress. The fact that almost all of our patients were under beta-1 blockade in contrast to our controls may partly explain why we did not have similar results on resting MBF and resting CVR as Range et al. 5 Previous studies have reported less beneficial effect of beta-blockers in patients with ischaemic or non-ischaemic heart failure and AF. 20, 21 It is currently unknown whether there is a correlation between the reduced MFR in patients with additional AF to heart failure and the impaired effect of beta-blocker treatment.
There is diversity in results regarding long-term outcome for patients with non-ischaemic heart failure and AF and the literature is confined. [22] [23] [24] [25] Furthermore, outcome studies have shown that MFR is associated with of adverse cardiac events and poorer prognosis in patients with non-ischaemic systolic heart failure 26, 27 and that catheter ablation for AF improved prognosis for patients with systolic heart failure. 28 Another newly published study found improvements in ventricular function after catheter ablation for AF but the particular study did not provide prognostic outcome data. 29 As the first study, our prospective cross-sectional study showed diminished MFR in patients with AF on top of non-ischaemic heart failure. It is still to be explored whether MFR provides prognostic information in patients with non-ischaemic systolic heart failure and additive AF, and which role MFR could play in selection of patients with heart failure for AF ablation.
Further research, that determine whether treatments targeted to the microvascular perfusion could improve the prognosis in patients with AF in addition to non-ischaemic systolic heart failure are warranted. Also, a randomized controlled trial on mortality and hospitalization of patients with non-ischaemic systolic heart failure randomized to AF ablation or standard rhythm and rate control treatment measuring MFR before and after ablation would be of interest, thereby to explore if MFR could contribute to patient selection for AF ablation.
Limitations
The overall control group differed from the AF regarding LBBB and CRT. However, LBBB was not associated to MFR either in univariable or multivariable analyses. Furthermore, in a sub analysis only including controls in sinus rhythm and without CRT, results for MFR remained unchanged. We have previously shown that myocardial perfusion was reduced in patients with Type 2 diabetes in addition to non-ischaemic heart failure. 30 Therefore, no patients with diabetes were included in this study. Nevertheless, our study population was similar to the overall population of patients with non-ischaemic systolic heart failure without diabetes. Further no patients with AF and only five patients without AF had received potential anti-anginous pharmacological treatment calcium antagonists or long-lasting nitrates.
Conclusion
Patients with non-ischaemic systolic heart failure had lower MFR than healthy controls, as measured with 82 Rb PET/CT, and MFR was even lower if patients had AF during scan. This difference between patients with and without AF remained significant even when controlling for potential confounders.
Supplementary data
Supplementary data are available at European Heart Journal -Cardiovascular Imaging online.
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